Posted in | News | Nanobusiness

Financial Rewards for Nanotech Science Authors and Peer Reviewers

The open-access Nanotech Science Journal (AZoJono) confirms revenue share with authors and peer reviewers at Nanotech 2007 Santa Clara, California

AZoJono -- The AZo Journal of Nanotechnology Online, residing on www.azonano.com has recently notified all authors and peer reviewers of their revenue share earnings for the last 12 month period.

Authors of the most popular papers have earned in excess of $500 for their contributions under the AZoNetwork Patented OARS (Open Access Revenue Share) scheme and peer reviewers have earned between $100 and $500 for their efforts.

Due to the free and open access nature of the journal and the size of the AZoNano.com online audience, which now exceeds 350,000 monthly visitor sessions, the most popular AZoJono paper has been viewed more than 17,000 times in the last 12 months.

Professor Chennupati Jagadish, Federation Fellow at the Australian National University and member of the AZoJono peer review team commented, "The AZo Journal of Nanotechnology Online (AZoJono) has been leading the open access publications in Nanotechnology with timely publication of manuscripts as well as rewarding authors, reviewers and editors for their efforts. The number of downloads of some of the papers published in AZoJono has been phenomenal."

Don Maclurcan, from the Institute for Nanoscale Technology, University of Technology, Sydney and an AZoJono author commented, "Quality publishing with an online, open-access journal that financially rewarded its authors and reviewers seemed beyond belief. I was wrong. Not only were my papers rapidly disseminated around the globe but I also received a nice Christmas bonus!"

Dr. Ian Birkby, the inventor of the OARS scheme and CEO of the operator of AZoNano.com, the online publisher, AZoNetwork, commented, “We are very pleased with the growth of this online journal and the fact that we can bring first rate Nanotech science to the widest possible online audience without any access barriers.”

He further stated, “Although we accept it is unlikely that financial reward is the main aim of authors, it is nevertheless significant that we have proved that high quality science writing can be rewarded financially whilst at the same time be distributed in a true open access format. Although the current results are but a small beginning, we believe they nevertheless represent a significant change in the scientific publishing landscape and we look forward to employing our Open Access Revenue Share scheme into other scientific disciplines”

###

About AZoNetwork
AZonetwork owns and operates www.azom.com The A to Z of Materials, www.azonano.com The A to Z of Nanotechnology, www.AZoBuild.com The A to Z of Building and Construction related technologies and www.news-medical.net the A to Z of medical news.

Based in Sydney Australia the company was founded in April 2000 and currently serves over 3 million monthly visitors sessions from the engineering, science, construction and medical sectors.

Over 95% of AZoNetwork earnings are derived from export sales outside of Australia.

www.azonetwork.com

About OARS
See https://www.azonano.com/journal_of_nanotechnology.asp#1

About AZoJono Peer Review Panel
See https://www.azonano.com/founding_editors.asp

AZoNetwork Head Office:
Suite 24, MVB
90 Mona Vale Road
Mona Vale
Sydney
NSW, 2103
Australia

Tel: Direct +61 2 9999 0070
Fax: +61 2 9999 0071
e-mail: [email protected]

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.